Developer docs
API playgroundTry for free, no card

Search company profiles

Agrematch

Full company profile

uuid0008x22

Namestring
Agrematch
Legal namestring
Agrematch
Websiteurl
agrematch.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Agrematch is an AI-driven R&D acceleration platform focused on function-first chemistry for enterprise R&D teams across agriculture, food and nutrition, specialty chemicals and materials, personal care and cosmetics, animal health and feed, and small-molecule discovery. The company's core offering is a five-module platform — Compound Predictor, Compound Analyzer, Library Analyzer, Compound Designer, and Chart Board — that combines proprietary chemistry data, predictive models, and expert workflows to evaluate compound activity, safety, toxicity, manufacturability, formulation fit, mix performance, environmental profile, and cost earlier in the discovery process. Agrematch also provides formulation intelligence, historical data activation (turning archived experimental data into searchable predictive infrastructure), and workflow integration that embeds AI into existing R&D processes. The platform generates and evaluates de novo molecules around defined functional goals, with Ruby (a patent-pending, computationally designed natural weed-control molecule) serving as a representative output. Agrematch operates a consultative enterprise sales motion through a 'Let's Talk' / 'Challenge us' contact form, engaging R&D teams on specific chemistry challenges via strategic R&D partnerships. Named customers include Qemetica, Adama, Nichino, ICL Group (also a strategic investor), Thrive Algorithmic Intelligence, and SVG Ventures. The company was founded in 2017, is headquartered in Rehovot, Israel, employs 11–50 people, and has raised funding from Ocean Azul Partners and ICL Planet Startup Hub across rounds in 2018, 2020, and 2023. The advisory board includes two Nobel laureates (Prof. Michael Levitt, Prof. Aaron Ciechanover) and senior executives from Monsanto, Syngenta, Corteva, ADAMA, and Pairwise.

Short descriptiontext

Agrematch is an AI-driven R&D platform that helps enterprise chemistry teams in agriculture, food, specialty chemicals, personal care, and animal health accelerate discovery through predictive modeling, de novo molecule generation, and formulation intelligence.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRehovot, Israel
HQ citystring
Rehovot
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
AI chemistry discovery, predictive compound modeling, formulation intelligence platform, enterprise R&D acceleration, de novo molecule design
Industry3 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYAFABAIAA
Crop Protection Formulations (EC, SC, WG, WP, SL)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Agrochemical Formulation & Toll Manufacturing
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Prepackaged Software7372
Product category
AI-powered chemistry R&D software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise AI R&D Services
TypeSubscription Recurring
Description

Agrematch operates as an applied AI R&D acceleration partner for industrial chemistry and biology. The company helps R&D teams use historical experimental knowledge, predictive modeling, and formulation intelligence. Revenue appears to come from strategic R&D partnerships and consulting-style engagements where Agrematch works alongside enterprise R&D teams on specific chemistry challenges.

agrematch.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Ruby
Description

A representative molecule from Agrematch's natural weed-control pipeline, computationally generated and optimized beyond traditional screening to deliver validated weed-control chemistry with commercial development potential.

agrematch.com
Core offering1 text field

Agrematch provides an AI-powered R&D acceleration platform for enterprise chemistry and biology teams. The platform combines proprietary chemistry data, predictive models, and expert workflows to help R&D teams evaluate compound options earlier, generate de novo molecules, predict formulations, and turn archived experimental data into AI-ready intelligence. Deliverables span discovery, formulation, predictive modeling, custom workflows, and AI-ready data, targeted at enterprise R&D teams in agriculture, food, specialty chemicals, personal care, and animal health.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • More than 60% of new chemical product launches fail according to EY-Parthenon research; Agrematch aims to reduce this by enabling earlier identification of weak candidates and development risks.
Product overview1 text field

Agrematch is an AI-powered R&D acceleration platform for industrial chemistry and biology. The platform consists of five core technology modules: Compound Predictor (for predictive assessment of compound properties), Compound Analyzer (for comparing chemistry options), Library Analyzer (for evaluating and prioritizing compound libraries at scale), Compound Designer (for generating and evaluating de novo molecules), and Chart Board (for organizing and presenting discovery insights). These modules work together to help enterprise R&D teams turn chemistry goals into stronger decisions across discovery, active mixes, formulations, predictive modeling, custom workflows, and AI-ready data. The platform also provides formulation intelligence, historical data activation, and workflow integration services.

Product and service6 records
1Compound Predictor
CategoryAI predictive modeling module
Description

Predicts and assesses compound properties such as activity, safety, toxicity, manufacturability, formulation fit, mix performance, environmental profile, and cost earlier in the R&D process for enterprise chemistry teams.

2Compound Analyzer
CategoryAI compound analysis module
Description

Compares individual compounds and chemistry options through a decision lens, enabling R&D teams to evaluate and rank candidates against multiple criteria.

3Library Analyzer
CategoryAI library analysis module
Description

Evaluates compound libraries at scale and turns large chemistry sets into clearer shortlists, enabling high-throughput prioritization of candidates for enterprise R&D teams.

4Compound Designer
CategoryGenerative molecule design module
Description

Generates and evaluates de novo molecules around defined functional goals and application requirements, computationally creating and optimizing novel compounds beyond traditional screening.

5Chart Board
CategoryDiscovery insights dashboard module
Description

Organizes, analyzes, and presents discovery insights during customer projects through tailored dashboards for tracking and communicating R&D decisions and outcomes.

6Ruby Natural Weed-Control Molecule
CategoryProprietary candidate molecule
Description

A representative patent-pending molecule from Agrematch's natural weed-control pipeline, computationally generated and optimized beyond traditional screening to deliver validated weed-control chemistry with commercial development potential.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Recursion is an AI-driven drug discovery company combining high-throughput biology with machine learning. It shares the AI-for-discovery DNA with Agrematch but operates at significantly larger scale and is concentrated in pharma rather than industrial chemistry.

TypeEmerging player
Description

Kebotix is an AI-driven materials discovery company focused on specialty chemicals and sustainable materials. It is comparable to Agrematch's specialty chemicals and PFAS alternative use cases, with a similar horizontal R&D acceleration approach.

TypeDirect peer
Description

Citrine Informatics applies AI to materials and chemicals R&D, helping enterprise teams accelerate discovery and formulation. It is highly comparable to Agrematch's materials, formulation, and specialty chemicals focus, with an overlapping horizontal platform strategy.

TypeDirect peer
Description

Schrödinger provides physics-based and AI-driven molecular simulation software for drug discovery and materials science. It is the closest direct peer to Agrematch's Compound Predictor and Compound Designer modules, though Schrödinger is more established in pharma while Agrematch focuses on agrochemical and specialty chemistry R&D.

TypeBroad incumbent
Description

Insitro applies machine learning to drug discovery and development, combining predictive models with experimental data. It is a broad incumbent peer in the AI-for-R&D category, comparable in approach (predictive + data-driven discovery) though focused on therapeutics.

TypeDirect peer
Description

Atomwise uses AI for small-molecule design and discovery, primarily in pharma and increasingly in agriculture and animal health. It is directly comparable to Agrematch's Compound Designer and predictive modeling capabilities, particularly for crop protection R&D.

TypeEmerging player
Description

Benchling provides a cloud R&D data platform for life sciences, including chemistry and biology workflows. It overlaps with Agrematch's historical data activation and workflow integration capabilities, although Benchling focuses more on data infrastructure than predictive molecule design.

TypeEmerging player
Description

Cradle uses generative AI to design proteins and biological molecules for biotech R&D. It overlaps with Agrematch's generative Compound Designer capability, though Cradle is focused on biologics rather than small-molecule industrial chemistry.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Agrematch

AI-powered chemistry R&D softwareagrematch.com

Agrematch is an AI-driven R&D platform that helps enterprise chemistry teams in agriculture, food, specialty chemicals, personal care, and animal health accelerate discovery through predictive modeling, de novo molecule generation, and formulation intelligence.

What Agrematch does

Agrematch is an AI-driven R&D acceleration platform focused on function-first chemistry for enterprise R&D teams across agriculture, food and nutrition, specialty chemicals and materials, personal care and cosmetics, animal health and feed, and small-molecule discovery. The company's core offering is a five-module platform — Compound Predictor, Compound Analyzer, Library Analyzer, Compound Designer, and Chart Board — that combines proprietary chemistry data, predictive models, and expert workflows to evaluate compound activity, safety, toxicity, manufacturability, formulation fit, mix performance, environmental profile, and cost earlier in the discovery process. Agrematch also provides formulation intelligence, historical data activation (turning archived experimental data into searchable predictive infrastructure), and workflow integration that embeds AI into existing R&D processes. The platform generates and evaluates de novo molecules around defined functional goals, with Ruby (a patent-pending, computationally designed natural weed-control molecule) serving as a representative output. Agrematch operates a consultative enterprise sales motion through a 'Let's Talk' / 'Challenge us' contact form, engaging R&D teams on specific chemistry challenges via strategic R&D partnerships. Named customers include Qemetica, Adama, Nichino, ICL Group (also a strategic investor), Thrive Algorithmic Intelligence, and SVG Ventures. The company was founded in 2017, is headquartered in Rehovot, Israel, employs 11–50 people, and has raised funding from Ocean Azul Partners and ICL Planet Startup Hub across rounds in 2018, 2020, and 2023. The advisory board includes two Nobel laureates (Prof. Michael Levitt, Prof. Aaron Ciechanover) and senior executives from Monsanto, Syngenta, Corteva, ADAMA, and Pairwise.

Agrematch firmographics

Firmographics
Name
Agrematch
Legal name
Agrematch
Website
https://agrematch.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Agrematch is an AI-driven R&D platform that helps enterprise chemistry teams in agriculture, food, specialty chemicals, personal care, and animal health accelerate discovery through predictive modeling, de novo molecule generation, and formulation intelligence.
Ownership category
akta.pro rank

Agrematch industry classification

Industry
Product category
AI-powered chemistry R&D software
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYAFABAIAA
Crop Protection Formulations (EC, SC, WG, WP, SL)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Agrochemical Formulation & Toll Manufacturing

Keywords

  • AI chemistry discovery
  • Predictive compound modeling
  • Formulation intelligence platform
  • Enterprise R&D acceleration
  • De novo molecule design

Where Agrematch is headquartered

Location

Headquarters

HQ city
Rehovot
HQ country
Israel
HQ region
Middle East

Markets served

Agrematch business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Enterprise AI R&D Services: Agrematch operates as an applied AI R&D acceleration partner for industrial chemistry and biology. The company helps R&D teams use historical experimental knowledge, predictive modeling, and formulation intelligence. Revenue appears to come from strategic R&D partnerships and consulting-style engagements where Agrematch works alongside enterprise R&D teams on specific chemistry challenges.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Agrematch product offering

Product offering

Core offering

Agrematch provides an AI-powered R&D acceleration platform for enterprise chemistry and biology teams. The platform combines proprietary chemistry data, predictive models, and expert workflows to help R&D teams evaluate compound options earlier, generate de novo molecules, predict formulations, and turn archived experimental data into AI-ready intelligence. Deliverables span discovery, formulation, predictive modeling, custom workflows, and AI-ready data, targeted at enterprise R&D teams in agriculture, food, specialty chemicals, personal care, and animal health.

Product overview

Agrematch is an AI-powered R&D acceleration platform for industrial chemistry and biology. The platform consists of five core technology modules: Compound Predictor (for predictive assessment of compound properties), Compound Analyzer (for comparing chemistry options), Library Analyzer (for evaluating and prioritizing compound libraries at scale), Compound Designer (for generating and evaluating de novo molecules), and Chart Board (for organizing and presenting discovery insights). These modules work together to help enterprise R&D teams turn chemistry goals into stronger decisions across discovery, active mixes, formulations, predictive modeling, custom workflows, and AI-ready data. The platform also provides formulation intelligence, historical data activation, and workflow integration services.

Differentiator

Problem solved

Functional benefit

Brands

  • Ruby: A representative molecule from Agrematch's natural weed-control pipeline, computationally generated and optimized beyond traditional screening to deliver validated weed-control chemistry with commercial development potential.

Products and services

  • Compound Predictor Predicts and assesses compound properties such as activity, safety, toxicity, manufacturability, formulation fit, mix performance, environmental profile, and cost earlier in the R&D process for enterprise chemistry teams.
  • Compound Analyzer Compares individual compounds and chemistry options through a decision lens, enabling R&D teams to evaluate and rank candidates against multiple criteria.
  • Library Analyzer Evaluates compound libraries at scale and turns large chemistry sets into clearer shortlists, enabling high-throughput prioritization of candidates for enterprise R&D teams.
  • Compound Designer Generates and evaluates de novo molecules around defined functional goals and application requirements, computationally creating and optimizing novel compounds beyond traditional screening.
  • Chart Board Organizes, analyzes, and presents discovery insights during customer projects through tailored dashboards for tracking and communicating R&D decisions and outcomes.
  • Ruby Natural Weed-Control Molecule A representative patent-pending molecule from Agrematch's natural weed-control pipeline, computationally generated and optimized beyond traditional screening to deliver validated weed-control chemistry with commercial development potential.

Quantifiable outcome

  • More than 60% of new chemical product launches fail according to EY-Parthenon research; Agrematch aims to reduce this by enabling earlier identification of weak candidates and development risks.

Companies that use Agrematch

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles6 records

Agrematch technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Agrematch partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights5 records

Agrematch competitors and assessment

Company assessment

Broad incumbents

  • Recursion: Recursion is an AI-driven drug discovery company combining high-throughput biology with machine learning. It shares the AI-for-discovery DNA with Agrematch but operates at significantly larger scale and is concentrated in pharma rather than industrial chemistry.
  • Insitro: Insitro applies machine learning to drug discovery and development, combining predictive models with experimental data. It is a broad incumbent peer in the AI-for-R&D category, comparable in approach (predictive + data-driven discovery) though focused on therapeutics.

Emerging players

  • Kebotix: Kebotix is an AI-driven materials discovery company focused on specialty chemicals and sustainable materials. It is comparable to Agrematch's specialty chemicals and PFAS alternative use cases, with a similar horizontal R&D acceleration approach.
  • Benchling: Benchling provides a cloud R&D data platform for life sciences, including chemistry and biology workflows. It overlaps with Agrematch's historical data activation and workflow integration capabilities, although Benchling focuses more on data infrastructure than predictive molecule design.
  • Cradle: Cradle uses generative AI to design proteins and biological molecules for biotech R&D. It overlaps with Agrematch's generative Compound Designer capability, though Cradle is focused on biologics rather than small-molecule industrial chemistry.

Direct peers

  • Citrine Informatics: Citrine Informatics applies AI to materials and chemicals R&D, helping enterprise teams accelerate discovery and formulation. It is highly comparable to Agrematch's materials, formulation, and specialty chemicals focus, with an overlapping horizontal platform strategy.
  • Schrödinger: Schrödinger provides physics-based and AI-driven molecular simulation software for drug discovery and materials science. It is the closest direct peer to Agrematch's Compound Predictor and Compound Designer modules, though Schrödinger is more established in pharma while Agrematch focuses on agrochemical and specialty chemistry R&D.
  • Atomwise: Atomwise uses AI for small-molecule design and discovery, primarily in pharma and increasingly in agriculture and animal health. It is directly comparable to Agrematch's Compound Designer and predictive modeling capabilities, particularly for crop protection R&D.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Agrematch social profiles

Digital presence

Agrematch financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Agrematch leadership team

Management profile

Number of profiles

Profiles14 records

Agrematch funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Agrematch M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agrematch

What does Agrematch do?

Agrematch provides an AI-powered R&D acceleration platform for enterprise chemistry and biology teams. The platform combines proprietary chemistry data, predictive models, and expert workflows to help R&D teams evaluate compound options earlier, generate de novo molecules, predict formulations, and turn archived experimental data into AI-ready intelligence. Deliverables span discovery, formulation, predictive modeling, custom workflows, and AI-ready data, targeted at enterprise R&D teams in agriculture, food, specialty chemicals, personal care, and animal health.

Is Agrematch a public or private company?

Agrematch is a private company. It is classified as venture growth investor backed and is currently operating.

When was Agrematch founded?

Agrematch was founded in 2020. It employs 11 to 50 people.

Where is Agrematch based?

Agrematch is headquartered in Rehovot, Israel, in the Middle East region.

How does Agrematch make money?

One revenue line is on record: enterprise AI R&D Services.

Who are Agrematch's main competitors?

Broad incumbents on record are Recursion and Insitro. Emerging players are Kebotix, Benchling and Cradle. Direct peers are Citrine Informatics, Schrödinger and Atomwise.

Does Agrematch have an API?

No public API is recorded for Agrematch.

What industry is Agrematch in?

Agrematch's product category is AI-powered chemistry R&D software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 5417 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Icl-Group4 Key Agriculture Trends To Watch Closely In 2025The article outlines four key AgroTech trends for 2025: AI-driven precision farming, carbon utilization with remote sensing, regenerative agriculture, and breakthroughs in ag biotechnology. ICL is positioned as a central actor in this transformation, actively investing in and partnering with startups like Agrematch, Lavie Bio, and PlantArcBio to deploy these innovations.FinSMEsAgrematch Receives Investment From ICLAgrematch, an Israeli AI agriTech startup, has secured investment from ICL Group to launch a multiyear joint program aimed at discovering novel crop nutrition solutions. The partnership will utilize Agrematch's AI platform to develop proprietary biostimulants and plant nutrition products for ICL’s global portfolio.foodnavigator.comAgrematch and ICL partnership will use AI to search for biostimulants to optimise agricultureICL and Agrematch partnered to use AI to discover novel crop nutrition solutions, with ICL investing in Agrematch and providing R&D access. Agrematch's AI platform screens billions of compounds, having already developed a natural herbicide in under 12 months. The partnership aims to accelerate discovery and reduce development risks.Icl-PlanetICL and Agrematch to Develop Novel Crop Nutrition Solutions via AIOn September 7, 2023, ICL Group announced an investment in Agrematch to develop innovative crop nutrition biostimulants using Agrematch's artificial intelligence technology. This collaboration aims to optimize plant health and increase yields while addressing the urgent need for sustainable crop nutrition products. The joint program is part of ICL's growth strategy within the agricultural sector.